METASTATIC TRIPLE-NEGATIVE BREAST CARCINOMA

Clinical trials for METASTATIC TRIPLE-NEGATIVE BREAST CARCINOMA explained in plain language.

Never miss a new study

Get alerted when new METASTATIC TRIPLE-NEGATIVE BREAST CARCINOMA trials appear

Sign up with your email to follow new studies for METASTATIC TRIPLE-NEGATIVE BREAST CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 13 Not yet recruiting 2 Not yet finished but already full! 6 Completed 1 Terminated 3

Scientists try to 're-sensitize' resistant cancer cells to chemo

Disease control Completed

This small, early-stage study tested whether a drug called bexarotene could make chemotherapy-resistant triple-negative breast cancer cells vulnerable to treatment again. Researchers gave bexarotene to 12 patients with advanced, taxane-resistant cancer, hoping it would change the…

Matched conditions: METASTATIC TRIPLE-NEGATIVE BREAST CARCINOMA

Phase: PHASE1 • Sponsor: National Cancer Centre, Singapore • Aim: Disease control

Last updated Mar 30, 2026 14:30 UTC

METASTATIC TRIPLE-NEGATIVE BREAST CARCINOMA

Get alerted when new METASTATIC TRIPLE-NEGATIVE BREAST CARCINOMA trials appear

Scientists try to 're-sensitize' resistant cancer cells to chemo